Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - an 11-Year Prospective Study.

about

Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - an 11-Year Prospective Study.

Item

http://www.wikidata.org/entity/Q45711780

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Predictors of Liver Fat and St ...... an 11-Year Prospective Study.

@en

Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease

@nl

type

Item

label

Predictors of Liver Fat and St ...... an 11-Year Prospective Study.

@en

Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease

@nl

prefLabel

Predictors of Liver Fat and St ...... an 11-Year Prospective Study.

@en

Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease

@nl

P1476

Predictors of Liver Fat and St ...... - an 11-Year Prospective Study

@en

P2093

Hannele Yki-Järvinen

http://www.w3.org/2001/XMLSchema#string

Markus T Kallio

http://www.w3.org/2001/XMLSchema#string

Nina Lundbom

http://www.w3.org/2001/XMLSchema#string

Sanja Sädevirta

http://www.w3.org/2001/XMLSchema#string

You Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Oxygen: modulator of metabolic zonation and disease of the liver.

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.

Longitudinal effects of MRI-measured hepatic steatosis on biomarkers of glucose homeostasis and hepatic apoptosis in obese youth.

P2888

s41598-017-14706-0

P304

14561

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-14706-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092462825

http://www.w3.org/2001/XMLSchema#string

P698

29109528

http://www.w3.org/2001/XMLSchema#string

P932

5674024

http://www.w3.org/2001/XMLSchema#string